Learn More
The aim of this study was to compare the efficacy and safety of once daily dosing with moxifloxacin (BAY 12-8039) with that of coamoxiclav given three times daily for the treatment of acute(More)
BACKGROUND More data on the efficacy and safety of ciprofloxacin in pediatric cystic fibrosis patients are needed. METHODS One hundred eight pediatric cystic fibrosis patients (ages 5 to 17 years)(More)